CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial ResultsSAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024.
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based FoodsThe innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves.
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the year end and fourth quarter ended December 31, 2024, before the stock market opens on Thursday, March 27, 2025. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) that same day.
CV Sciences Unveils New Aura Collection THC Fizz TabletsThe innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home.
Pharmaceutical & Hemp Wellness Segments Of Cannabidiol Market Could See the Fastest Growth Rates Through 2028Palm Beach, FL – November 15, 2021 – FinancialNewsMedia.com News Commentary – Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such as anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and […]
